Exercise-Induced Gut Permeability in Normal-weight Obesity
Indicators of Gut Permeability in Normal-weight Obesity in Response to Brief, Maximal and Sustained, Submaximal Exercise
1 other identifier
interventional
30
1 country
1
Brief Summary
Exercise acutely increases gut permeability and inflammation, even in healthy populations. However, whether this response differs in groups at-risk for CVD that present with low-grade inflammation (e.g., normal-weight obesity) has yet to be examined. The investigators aim to measure serum indicators of gut permeability in those with normal-weight obesity pre- and post-short, intense exercise and sustained, moderate exercise
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 10, 2023
CompletedFirst Submitted
Initial submission to the registry
May 4, 2023
CompletedFirst Posted
Study publicly available on registry
June 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2023
CompletedJune 5, 2023
June 1, 2023
7 months
May 4, 2023
June 2, 2023
Conditions
Outcome Measures
Primary Outcomes (5)
Serum concentrations of FABP2 following short, intense exercise
The investigators will examine peak and absolute change in this indicator of gut permeability after the VO2 max test on a cycle ergometer.
Approximately 8 months
Serum concentrations of LBP following short, intense exercise
The investigators will examine peak and absolute change in this indicator of gut permeability after the VO2 max test on a cycle ergometer.
Approximately 8 months
Serum concentrations of sCD14 following short, intense exercise
The investigators will examine peak and absolute change in this indicator of gut permeability after the VO2 max test on a cycle ergometer.
Approximately 8 months
Serum concentrations of FABP2 following sustained, moderate exercise
The investigators will examine peak and absolute change in this indicator of gut permeability after 45-minutes of exercise at 65% VO2 max on a cycle ergometer.
Approximately 8 months
Serum concentrations of IL-6 following sustained, moderate exercise
The investigators will examine peak and absolute change in this inflammatory marker after 45-minutes of exercise at 65% VO2 max on a cycle ergometer.
Approximately 8 months
Secondary Outcomes (4)
VO2 Max
Approximately 8 months
Respiratory exchange ratio (RER) during VO2 max test
Approximately 8 months
Maximum workload during exercise sessions
Approximately 8 months
Heart rate dynamics during exercise sessions
Approximately 8 months
Other Outcomes (6)
Body fat percent assessment with dual-energy X-ray absorptiometry (DXA).
Approximately 8 months
Absolute body fat assessment with dual-energy X-ray absorptiometry (DXA)
Approximately 8 months
Lean mass percent assessment with dual-energy X-ray absorptiometry (DXA)
Approximately 8 months
- +3 more other outcomes
Study Arms (3)
Normal weight and low body fat percent
ACTIVE COMPARATORThe low risk comparator group for this study will consist of individuals with normal BMI (18.5 - 24.9 kg/m2) and body fat percent \< 25% (male) or \< 35% (female).
Normal-weight obesity
EXPERIMENTALIndividuals with normal-weight obesity will be defined as having normal BMI (18.5 - 24.9 kg/m2), body fat percent \> 25% (male) or \> 35% (female).
Overt obesity and high body fat percent
ACTIVE COMPARATOROvert obesity (BMI \> 30 kg/m2) with high body fat percent (\> 25% \[male\] or \> 35% \[female\]) will be used as a high-risk comparator group.
Interventions
All participants will complete two exercise sessions: 1. VO2 max test on a cycle ergometer 2. Moderate exercise session (45 minutes at 65% measured VO2 max)
Eligibility Criteria
You may qualify if:
- Control group: normal BMI, body fat percentage \< 25% (male) or \< 35% (female)
- Normal-weight obesity: normal BMI, body fat percentage \> 25% (male) or \> 35% (female)
- Overt obesity: BMI in obesity range, body fat percentage \> 25% (male) or \> 35% (female)
You may not qualify if:
- Presence of pacemaker
- Pregnant
- Postmenopausal status
- History of chronically using of tobacco products, illicit drugs, anti-inflammatory drugs (e.g., NSAIDs), lipid lowering drugs
- Recent use of antibiotics (\< 6 weeks) and NSAIDs (\< 3 days)
- Established cardiometabolic disease (e.g., cardiovascular disease, type 2 diabetes) diseases inflammatory in nature (e.g., rheumatoid arthritis, inflammatory bowel disease), and/or diagnosed irritable bowel syndrome.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
208 Nancy Randolph Davis, Oklahoma State University
Stillwater, Oklahoma, 74078, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Nutritional Sciences
Study Record Dates
First Submitted
May 4, 2023
First Posted
June 5, 2023
Study Start
January 10, 2023
Primary Completion
August 1, 2023
Study Completion
August 1, 2023
Last Updated
June 5, 2023
Record last verified: 2023-06